Crimson staff writer

Paul E. Alexis

Latest Content


Larry Summers Talks Inflation at Harvard IOP Forum

Former U.S. Treasury Secretary Lawrence H. Summers discussed his concerns about the continued risk of inflation for the global economy at a Harvard Institute of Politics forum Thursday evening.


Patriots Owner Robert Kraft Donates $24 Million to Harvard Business School

The Kraft family, which owns the New England Patriots, donated $24 million to Harvard Business School earlier this month to establish the Robert K. Kraft Family Fellowship Fund, which will be the largest endowed fellowship fund at the school.


WHO Director Talks Health Equity and Pandemic Response at Harvard Lecture

World Health Organization Director-General Tedros Adhanom Ghebreyesus discussed the global pandemic response and health equity on Friday at the Kennedy School’s annual Robert S. McNamara Lecture on War and Peace.


Legal and Medical Experts Discuss Alternative Approaches for Aiding Families Struggling With Substance Abuse

Legal and medical experts discussed how to support families struggling with substance abuse in a Tuesday virtual panel jointly hosted by Massachusetts General Hospital's Center for Law, Brain, and Behavior and Harvard Law School's Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics.


Bioethics Panel Discusses Smart Device Disease Diagnosis

Researchers, lawyers, and physicians discussed the ethical implications of using smart devices to collect data for diagnosing medical conditions in a virtual panel hosted by the Harvard Medical School Center for Bioethics on Friday.


Boston Children’s Hospital CEO Talks About Health Equity

Boston Children’s Hospital CEO Kevin B. Churchwell discussed equity, diversity, and inclusion in pediatrics at a virtual Q&A hosted by the Harvard School of Public Health Friday.


HSPH Study Affirms Cost Benefit of Preventing Emerging Diseases

A study led by Harvard School of Public Health researcher Aaron S. Bernstein found that the cost of preventing diseases transmitted from animals to humans is just five percent of the estimated value of lives lost from emerging infectious diseases.